Find and Pitch Jounalists, Get Your Story Covered

Tags: endocrinology obesity graves' disease glucokinase osteoporosis

	Profile	Recent Articles on Subject
1	Rick Lange, MD, Texas Tech; Elizabeth Tracey MedPage Today Texas Tech University System, advancing higher education and health care. Lubbock, Texas higher educationhealth care	Body Roundness to Predict Cardiovascular Disease; Myopia on the Rise - 13 days ago Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs - 3 months ago GLP-1 Agonists in Adolescents and Young Adults; Benefits of Cancer Drug Trials - 5 months ago Heat and Cardiovascular Death; Time-Restricted Eating or Caloric Restriction in T2D - 12 months ago
2	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Hormone Therapy Reduced Insulin Resistance in Healthy Postmenopausal Women - about 1 month ago Hormone Therapy Use for Menopause Has Remained Low Since 2007 - about 1 month ago
3	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - about 1 month ago
4	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances With Various Therapies Targeting DLL3 in Lung Neuroendocrine Tumors - about 1 month ago
5	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Lilly lays down $1B to be ‘first in biology’ with obesity gene therapies - about 1 month ago To penetrate crowded GLP-1 field, Rivus Pharma is taking a metabolic approach - 7 months ago
6	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - about 1 month ago
7	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - about 1 month ago STAT+: What comes after Wegovy? The quest to eradicate obesity - 10 months ago Obesity drugs’ next tests, and rising threats: 3 chronic disease stories to watch - 10 months ago STAT+: Wegovy may have another helpful trick: fighting inflammation via the brain, study finds - 10 months ago
8	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Condition Watch, August 2024: Dermatology - about 2 months ago FDA Grants Orphan Drug Designation to PT217 for Neuroendocrine Carcinoma - about 2 months ago Investigational GLP-1 Medication Found to Reduce Body Weight - 8 months ago
9	Kristen Monaco MedPage Today	Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update - about 2 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 3 months ago Type D Personality and Hypothyroidism; Infertility and eGFR; Fracture Algorithm - 6 months ago Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes - 7 months ago Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D - 8 months ago Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism - 9 months ago Health Record Trigger Boosted Screening for Primary Aldosteronism - 9 months ago Lower Insulin Costs; Older Folks Want Obesity Meds Covered; Global Ozempic Woes - 10 months ago Hibernating Squirrels for Obesity? Dialysis Warning; Endocrinology and Telehealth - 10 months ago Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis - 11 months ago Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes - 11 months ago Tone Matters in Weight-Loss Talks; Salt and Diabetes; Nix Brominated Veg Oil? - 12 months ago Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancer - 12 months ago Diabetes in Night Owls; 'Paradigm-Shifting' Drugs; Transgender Trials Unethical? - about 1 year ago
10	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	Theramex’s Eladynos recommended by NICE for post-menopausal bone disease - about 2 months ago

Journalists covering endocrinology